On the efficacy of influenza and COVID-19 vaccines
The global market volume of the vaccine business is up in the double-digit billion dollars and is currently experiencing rapid growth. Only four pharmaceutical companies control 90 percent of the market. They have a great economic interest in ensuring that the effectiveness of the vaccines they sell turn out to be particularly high in the very studies they fund themselves. It is all the more important that independent organisations compare these studies and check their scientific evidence, and that medical laymen learn which studies they can trust and how their results should be interpreted regarding the effectiveness of the vaccines. Because in the end the active ingredients of these vaccines end up in their bodies and can possibly cause more damage than they protect against the virus.
KARSTEN MONTAG, 14. Juni 2021, 0 Kommentare
Clade X – A bioweapon for population reduction
In 2018, a small circle of government experts in Washington rehearsed a pandemic triggered by a bioweapon, scripted to be caused by a group that wanted to use it to reduce the world's population to achieve, literally, ...
PAUL SCHREYER, 8. März 2021, 0 Kommentare
Covid-19 – a case for medical detectives
The numerous and disproportionately frequent deaths of Covid-19 patients with dark skin colour and from southern countries are apparently also the result of a drug-related mistreatment. Affected are people with a ...
WOLFGANG WODARG, 2. Mai 2020, 0 Kommentare
The Gates Foundation's Vaccination Activism
In the corona crisis, billionaire Bill Gates makes a high-profile appearance as a vaccination activist. The essence: a vaccine is the solution, it is only a matter of implementation. According to Gates, the G20 should ...
ERIC WAGNER, 16. April 2020, 0 Kommentare
Weitere Artikel